| Literature DB >> 35889274 |
Pawee Sitthichai1, Setinee Chanpirom1,2, Tharakorn Maneerat3,4,5, Rawiwan Charoensup5,6, Thapakorn Tree-Udom1,2, Punyawatt Pintathong1, Surat Laphookhieo3,4, Tawanun Sripisut1,2.
Abstract
Kaempferia parviflora (Black ginger) is used widely in medical fields as an anti-microorganism and anti-inflammation. In this study, the aim was to evaluate the in vitro and in vivo anti-acne efficacy of black ginger extract. The results indicate that the methanol and ethanol extracts showed the highest total phenolic contents, without a significant difference, whereas the n-hexane extract showed the highest total flavonoid content. Nine flavones were detected using UPLC-QTOF-MS, and the ethyl acetate extract showed the highest amount of 5,7-dimethoxyflavone (DMF) according to HPLC. Antibacterial activity against Staphylococcus aureus, S. epidermidis, and Cutibacterium acnes was observed. All the extracts showed antimicrobial activity against C. acnes, revealing MICs in the range of 0.015 to 0.030 mg/mL, whereas the ethyl acetate extract inhibited the growth of S. epidermidis with a MIC of 3.84 mg/mL. In addition, the ethyl acetate extract showed the highest activity regarding nitric oxide inhibition (IC50 = 12.59 ± 0.35 µg/mL). The ethyl acetate extract was shown to be safe regarding cell viability at 0.1 mg/mL. The anti-acne efficacy was evaluated on volunteers. The volunteers were treated in two groups: one administered a 0.02% ethyl acetate extract gel-cream (n = 9) and one administered a placebo (n = 9) for 6 weeks. The group treated with the gel-cream containing the extract showed 36.52 and 52.20% decreases in acne severity index (ASI) after 4 and 6 weeks, respectively, and 18.19 and 18.54% decreases in erythema, respectively. The results suggest that K. parviflora could be a potent active ingredient in anti-inflammatory and anti-acne products.Entities:
Keywords: Kaempferia parviflora; anti-acne; anti-inflammatory activity; antimicrobial activity; cytotoxicity; total flavonoid content
Mesh:
Substances:
Year: 2022 PMID: 35889274 PMCID: PMC9321094 DOI: 10.3390/molecules27144401
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Extraction yield, total phenolic, and flavonoid content of each K. parviflora ex-tract.
| Conditions | Yield (%) | TPC | TFC |
|---|---|---|---|
| Methanol ext. | 19.69 | 58.45 ± 2.85 a | 47.92 ± 0.92 d |
| Ethanol ext. | 13.06 | 52.28 ± 3.85 a, b | 57.56 ± 3.33 c |
| Acetone ext. | 12.85 | 42.05 ± 4.16 c | 62.22 ± 2.25 b, c |
| Ethyl acetate ext. | 13.18 | 45.46 ± 4.42 b, c | 62.90 ± 0.97 b, c |
| Dichloromethane ext. | 14.52 | 36.69 ± 0.53 c, d | 64.82 ± 3.15 b |
| 2.07 | 32.31 ± 0.43 d | 127.09 ± 1.00 a |
TPC: total phenolic content; TFC: total flavonoid content; different letters (a, b, c and d) indicate statistical significance at p < 0.05. Results are expressed as means ± SDs.
Figure 1UPLC-QTOF-MS chromatograms of K. parviflora extracted using different solvents; 5,7,4′-Trimethoxyflavone (1), 3,5,7-Trimethoxyflavone (2), 5-Hydroxy-7,4′-dimethoxyflavone (3), 5,7-Dimethoxyflavone (4), 3,5,7,4′-Tetramethoxyflavone (5), 5-Hydroxy-3,7,3′,4′-tetramethoxyflavone (6), 5-Hydroxy-7-methoxyflavone (7), 5-Hydroxy-3,7-dimethoxyflavone (8), and 5-Hydroxy-3,7,4′-trimethoxyflavone (9).
Figure 2HPLC chromatogram and DMF peak for each K. parviflora extract; methanol extract (A), ethyl acetate extract (B), n-hexane extract (C), and standard DMF compound (D).
HPLC analysis of DMF in each K. parviflora extract.
| Sample | DMF Amount (mg/g Extract) |
|---|---|
| Methanol ext. | 92.72 ± 3.21 b |
| Ethyl acetate ext. | 119.18 ± 4.02 a |
| 48.46 ± 1.70 c |
Different letters (a, b and c) indicate statistical significance at p < 0.05. Results are expressed as means ± SDs.
Antimicrobial activities of K. parviflora extracts.
| Samples | MIC (mg/mL) | ||
|---|---|---|---|
|
|
|
| |
| Methanol ext. | >3.84 | >3.84 | 0.03 |
| Ethanol ext. | >3.84 | >3.84 | 0.03 |
| Acetone ext. | >3.84 | >3.84 | 0.015 |
| Ethyl acetate ext. | >3.84 | 3.84 | 0.015 |
| Dichloromethane ext. | >3.84 | >3.84 | 0.015 |
| >3.84 | >3.84 | 0.03 | |
| Vancomycin | 0.0005 | 0.001 | 0.001 |
| Gentamycin | <0.0001 | <0.0001 | 0.004 |
Nitric oxide inhibition by K. parviflora extracts.
| Samples | IC50 (µg/mL) |
|---|---|
| Methanol ext. | 20.02 ± 0.20 c |
| Ethanol ext. | 19.51 ± 0.62 c |
| Acetone ext. | 13.47 ± 0.17 b |
| Ethyl acetate ext. | 12.59 ± 0.35 a |
| Dichloromethane ext. | 13.91 ± 0.15 b |
| 13.95 ± 0.21 b | |
| Indomethacin | 23.13 ± 1.51 d |
Different letters (a, b, c and d) indicate statistical significance at p < 0.05. Results are expressed as means ± SDs.
Figure 3Percent changes in the acne severity index (ASI) scores between Groups A (CKP) and B (CB; control) in Weeks 0, 2, 4, and 6; * represents a significant difference (p < 0.05). Values represent means ± SEM.
Figure 4Percent changes in the erythema index between Groups A (CKP) and B (CB; control) in Weeks 0, 2, 4, and 6; * represents a significant difference (p < 0.05). Values represent means ± SEM.
Figure 5One representative acne volunteer in Week 0 (a–c) and Week 6 (d–f).
Grading criteria for skin erythema and edema.
| Grade | Erythema | Edema |
|---|---|---|
| 0 | Negative reaction | Negative reaction |
| +1 | Light erythema | Very slight edema |
| +2 | Clearly visible erythema | Slight edema |
| +3 | Moderate erythema | Moderate edema |
| +4 | Intense erythema | Strong edema |
Mean irritation index (M.I.I.) interpretation.
| M.I.I. Value | Irritancy |
|---|---|
| M.I.I. < 0.50 | No irritation |
| 0.50 ≤ M.I.I. < 2.00 | Mild irritation |
| 2.00 ≤ M.I.I. < 5.00 | Moderate irritation |
| M.I.I. > 5.00 | Strong irritation |